Clinical Trial

Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the safety and efficacy of the umbilical cord blood mononuclear cells (UCB-MNCs) therapy for chronic radiation enteritis (CRE) by observing factors related to the therapeutic effect and adverse reactions of UCB-MNCs in treating CRE.
Trial Details
NCT Number NCT07175207
Lead Sponsor Zhejiang Cancer Hospital
Conditions Chronic Radiation Induced Intestinal Injury, Chronic Radiation Enteritis
Enrollment 10 participants
Start Date 2025-10-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-16